Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 14, Number 6—June 2008


Validation of Syndromic Surveillance for Respiratory Pathogen Activity

Cees van den Wijngaard*Comments to Author , Liselotte van Asten*, Wilfrid van Pelt*, Nico J.D. Nagelkerke†, Robert Verheij‡, Albert J. de Neeling*, Arnold Dekkers*, Marianne A.B. van der Sande*, Hans van Vliet*, and Marion P.G. Koopmans*
Author affiliations: *National Institute for Public Health and the Environment, Bilthoven, the Netherlands; †United Arab Emirates University, Al-Ain, United Arab Emirates; ‡Netherlands Institute of Health Services Research, Utrecht, the Netherlands;

Main Article

Table 5

Syndrome variation that can be explained by either the pathogen counts, 
seasonal terms, or pathogen counts and seasonal terms together*

Syndrome data Pathogens, % Pathogens and seasonal terms, % Seasonal terms, %
Absenteeism 68 80 79
GP 86 89 75
Pharmacy 80 87 77
Hospitalization 84 88 75
Laboratory submissions 61 63 53
Mortality 78 78 52

*Estimated by 3 different R2 values for each registry: 1) for the syndromes explained by pathogen counts alone; 2) after adding seasonal terms to the pathogen model; and 3) for the syndromes explained by seasonal terms alone (sine and cosine parameters). GP, general practice.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO